Otospondylomegaepiphyseal dysplasia

From WikiMD's Food, Medicine & Wellness Encyclopedia

Otospondylomegaepiphyseal dysplasia (OSMED) is a rare genetic disorder that affects the development of the skeleton, hearing, and vision. It is characterized by short stature, severe hearing loss, and problems with vision. The condition is caused by mutations in the COL11A2 gene.

Symptoms and Signs[edit | edit source]

The most common symptoms of OSMED include short stature, severe hearing loss, and problems with vision. Other symptoms may include joint pain, skeletal abnormalities, and facial deformities. The severity of symptoms can vary greatly among individuals with the condition.

Causes[edit | edit source]

OSMED is caused by mutations in the COL11A2 gene. This gene provides instructions for making a protein that is essential for the normal development of cartilage and the formation of collagen, a protein that provides structure and strength to tissues and organs throughout the body. Mutations in the COL11A2 gene disrupt the normal development of cartilage and collagen, leading to the symptoms of OSMED.

Diagnosis[edit | edit source]

Diagnosis of OSMED is based on the presence of characteristic symptoms and signs. Genetic testing can confirm the diagnosis by identifying a mutation in the COL11A2 gene.

Treatment[edit | edit source]

There is currently no cure for OSMED. Treatment is focused on managing symptoms and improving quality of life. This may include hearing aids for hearing loss, physical therapy for joint pain and mobility issues, and surgery to correct skeletal abnormalities.

Prognosis[edit | edit source]

The prognosis for individuals with OSMED varies depending on the severity of symptoms. With appropriate management and treatment, many individuals with the condition can lead productive lives.

See Also[edit | edit source]

References[edit | edit source]

‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD